Master Alliance Provisions Guide (MAPGuide)

MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement

  • Business model | Quality management

3. Development and Registration

[…]

3.3 Quality. If Licensee elects to commercialize Licensed Products, Licensee will commercialize the Licensed Products in a manner consistent with: (i) World Health Organization (“WHO”) pre-qualification standards; or (ii) the standards of any Stringent Regulatory Authority (“Stringent Regulatory Authority”), as defined by the WHO. Where such approvals are not yet available, the Licensee may obtain temporary approval through a WHO Expert Review Panel.